ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "adverse events and cancer treatments"

  • Abstract Number: 2146 • 2019 ACR/ARP Annual Meeting

    Complications of Immune Checkpoint Inhibitor Therapy in Patients with and Without Pre-existing Rheumatologic Disease

    Emily Carroll1, Amanda Leiter 2, Danielle Brooks 1, Jennifer Ben Shimol 3, Elliot Eisenberg 1, Matthew Galsky 4, Emily Gallagher 5 and Margrit Wiesendanger 3, 1Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, 2Division of Endocrinology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, 3Division of Rheumatology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, 4Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, 5Division of Endocrinology, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York

    Background/Purpose: Immune checkpoint inhibitors (ICIs) are effective therapies in the treatment of many cancers, but their use has been linked with immune-related adverse events (irAEs).…
  • Abstract Number: 361 • 2018 ACR/ARHP Annual Meeting

    Risk Factors of Immune-Related Adverse Events in Patients Treated with Anti-Programmed Cell Death 1 Antibody Pembrolizumab

    In Young Kim1, Yeonghee Eun1, Hyungjin Kim1, Joong Kyong Ahn2, Eun-Jung Park3, Chan Hong Jeon4, Jinseok Kim5, Hoon-Suk Cha1, Eun-Mi Koh1 and Jaejoon Lee1, 1Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South), 2Department of Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South), 3Department of Medicine, National Medical Center, Seoul, Korea, Republic of (South), 4Department of Medicine, Soonchunhyang University College of Medicine, Bucheon, Korea, Republic of (South), 5Department of Medicine, Jeju National University Hospital, University of Jeju School of Medicine, Jeju, Korea, Republic of (South)

    Background/Purpose: Immune checkpoint inhibitors have been established as a novel standard treatment for various types of malignancies. However, these new class of drugs have led…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.